May 22 (Reuters) - Iconovo AB ICO.ST :
* INITIATES STRUCTURED PROCESS FOR OUT-LICENSING OF ICOPRE
WITH A
GLOBAL INVESTMENT BANK
* NEGOTIATIONS WITH UNNAMED PHARMACEUTICAL COMPANY REGARDING
ICOPRE, ANNOUNCED IN JAN 2023, ARE BEING CONDUCTED AT SLOWER
PACE THAN BEFORE
* HAS EXPERIENED INCREASED INTEREST IN INHALER PLATFORM FROM
OTHER
PHARMACEUTICAL COMPANIES
* STRUCTURED PROCESS TO MAXIMIZE COMMERCIAL VALUE OF FUTURE
AGREEMENT
* PROCESS FOR ICOPRE IS EXPECTED TO BE COMPLETED IN FIRST
HALF OF
2024
Source text for Eikon: ID:nMFN3HNsnd
Further company coverage: ICO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))